Brief: Biophytis Updates On Sara-Obs Study Results
14/12/2020 07:13
Dec 14 (Reuters) - Biophytis SA ALBPS.PA :
* PRESENTS SARA-OBS STUDY RESULTS AT THE ANNUAL CONFERENCE OF THE SOCIETY ON
SARCOPENIA, CACHEXIA AND WASTING DISORDERS
* SARA-OBS STUDY SHOWED A RAPID DETERIORATION OF THE MOBILITY IN
PARTICIPANTS AS
MEASURED BY TWO WALKING TESTS
Further company coverage: ALBPS.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon